Draft Pharma Patent Examination Guidelines 2026
The Office of the Controller General of Patents, Designs & Trade Marks (CGPDTM) has released Draft Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals, 2026…
Pharmaceutical patents
68 articles
Two Painkillers, One Crystal, Zero Patent
Esteve Pharmaceuticals took its rejected co-crystal patent for tramadol and celecoxib to the Delhi High Court, arguing the combination showed real synergy. The court had to decide whether…
Quia Timet Patent Injunction Stops Intas’s Dabrafenib Launch
Novartis AG sought a quia timet patent injunction against Intas Pharmaceuticals Limited before the Delhi High Court, alleging that regulatory filings and an investigation report revealed imminent infringement…
Patent Opposition Board Report: Can you challenge it before the final order?
When is a patent opposition board recommendation ripe for a writ petition, and when is it simply too soon? The Madras High Court tackled this question in a…
Wanted Dead or Alive: Delhi High Court Holds Patent Revocation Survives Expiry and Section 107 Defence
In the case of Boehringer Ingelheim Pharma GmbH & Co. KG v. Controller of Patents & Anr., the Delhi High Court addressed two important questions under the Patents…
Intellepedia’s Top Patent Articles of 2025: A Year in Review
A concise roundup of Intellepedia’s most impactful patent law articles of 2025, highlighting key judicial and Patent Office developments every IP practitioner should note.
Dr Reddy’s Semaglutide Exports to Continue as Court Denies Interim Relief to Novo Nordisk
The Delhi High Court refused Novo Nordisk interim relief against Dr Reddy’s, finding that the Semaglutide species patent faces serious validity challenges in light of the earlier genus…
Section 3(i) Rejection Set Aside: Court Clarifies Scope of Pharmaceutical Patent Claims
The Delhi High Court reiterated that a properly drafted pharmaceutical composition claim cannot be dismissed as a “method of treatment” under Section 3(i), and has sent Medilabo’s neurodegenerative…
Akebia’s patent for Anemia therapy gets fresh blood from Court
In a recent case the Madras High Court upheld Akebia Therapeutics’ appeal on its anaemia treatment patent, interpreting Section 59 to allow claim amendments from treatment methods to…
AbbVie’s Patent Refusal Upheld over Impermissible Shift from Treatment to Product Claims
The Delhi High Court has dismissed AbbVie's appeal regarding the refusal of their patent application for an anti-cMet antibody-drug conjugate. The court found the proposed amendments exceeded permissible…